Restructuring Pharmaceutical Global Supply Chains after COVID-19

Raghbendra Jha, Ashok Sharma

Research output: Contribution to Newspaper/Magazine/BulletinArticle


The COVID-19 outbreak provides India’s pharmaceutical industry a big opportunity, but responsibility as well. India is poised to be a key destination for manufacturing alternatives as the world looks to diversify the global supply chain away from China.
Original languageEnglish
Number of pages3
Specialist publicationAustralian Journal of International Affairs
PublisherAustralian Institute of International Affairs
Publication statusPublished - 21 May 2020


Dive into the research topics of 'Restructuring Pharmaceutical Global Supply Chains after COVID-19'. Together they form a unique fingerprint.

Cite this